AllianceBernstein’s GALENA BIOPHARMA INC COM RXII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-137,500
| Closed | -$48K | – | 3087 |
|
|
2016
Q3 | $48K | Sell |
137,500
-43,300
| -24% | -$15.1K | ﹤0.01% | 2957 |
|
|
2016
Q2 | $84K | Buy |
180,800
+73,500
| +68% | +$34.1K | ﹤0.01% | 2928 |
|
|
2016
Q1 | $146K | Sell |
107,300
-32,400
| -23% | -$44.1K | ﹤0.01% | 2774 |
|
|
2015
Q4 | $205K | Hold |
139,700
| – | – | ﹤0.01% | 2742 |
|
|
2015
Q3 | $221K | Hold |
139,700
| – | – | ﹤0.01% | 2745 |
|
|
2015
Q2 | $237K | Buy |
139,700
+57,300
| +70% | +$97.2K | ﹤0.01% | 2822 |
|
|
2015
Q1 | $115K | Sell |
82,400
-17,100
| -17% | -$23.9K | ﹤0.01% | 2997 |
|
|
2014
Q4 | $150K | Hold |
99,500
| – | – | ﹤0.01% | 2892 |
|
|
2014
Q3 | $205K | Sell |
99,500
-13,400
| -12% | -$27.6K | ﹤0.01% | 2762 |
|
|
2014
Q2 | $345K | Sell |
112,900
-42,435
| -27% | -$130K | ﹤0.01% | 2628 |
|
|
2014
Q1 | $388K | Buy |
155,335
+148,200
| +2,077% | +$370K | ﹤0.01% | 2527 |
|
|
2013
Q4 | $35K | Sell |
7,135
-15,500
| -68% | -$76K | ﹤0.01% | 3030 |
|
|
2013
Q3 | $51K | Sell |
22,635
-16,861
| -43% | -$38K | ﹤0.01% | 3036 |
|
|
2013
Q2 | $88K | Buy |
+39,496
| New | +$88K | ﹤0.01% | 2954 |
|
AllianceBernstein's RXII Position: Q4 2016 in Review
AllianceBernstein sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 137,500 shares — an estimated $48K sold.
AllianceBernstein first reported a position in RXII in Q2 2013 and held it in 14 quarters. The position peaked at $388K in Q1 2014. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.
- AllianceBernstein reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
- AllianceBernstein sold 137,500 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $48K.
- AllianceBernstein first reported a position in GALENA BIOPHARMA INC COM in Q2 2013 and held it in 14 quarters.
- AllianceBernstein's GALENA BIOPHARMA INC COM position peaked at $388K in Q1 2014.
- 0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.
Based on AllianceBernstein's 13F filing for Q4 2016, filed 13 Feb 2017.